发明名称 Method of inhibiting regulatory T-cell activity by administering an antibody that inhibits interleukin 35
摘要 Methods for regulating T cell function in a subject, particularly regulatory T cell activity are provided. Methods of the invention include administering to a subject a therapeutically effective amount of an Interleukin 35-specific binding agent, such as an antibody or small molecule inhibitor. The invention further provides methods for enhancing the immunogenicity of a vaccine or overcoming a suppressed immune response to a vaccine in a subject, including administering to the subject a therapeutically effective amount of an IL35-specific binding agent and administering to the subject a vaccine. In one embodiment the vaccine is a cancer vaccine.
申请公布号 US8784807(B2) 申请公布日期 2014.07.22
申请号 US200712441166 申请日期 2007.09.24
申请人 St. Jude Children's Research Hospital 发明人 Vignali Dario;Workman Creg;Collison Lauren;Vignali Kate
分类号 A61K39/395 主分类号 A61K39/395
代理机构 Alston & Bird LLP 代理人 Alston & Bird LLP
主权项 1. A method of inhibiting a regulatory T-cell function in a subject, comprising administering to a subject in need of inhibiting a regulatory T-cell function a therapeutically effective amount of a specific binding agent, wherein said specific binding agent comprises an antibody that inhibits Interleukin 35 (IL35) activity, wherein the therapeutically effective amount of said antibody inhibits a regulatory T-cell function in said subject.
地址 Memphis TN US